Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Tmunity Therapeutics

Main focus: CAR-T cell therapies for the treatment of cancer

Company stage: Clinical

Diseases: Prostate cancer, lung cancer, and ovarian cancer, other undisclosed diseases.

Genome editing tool: Undisclosed

Funding stage: Private

Location: Philadelphia, PA, USA

Website: https://www.tmunity.com/

Pipeline:https://www.tmunity.com/pipeline

Tmunity Therapeutics is a privately held biotherapeutics company focused on developing the next generation of T cell therapies. Tmunity is working closely with the University of Pennsulvania, where the company was founded. The company is developing multiple different such as engineered T cell receptors, regulatory T cells and CAR-T cells.

Tags

HashtagTmunity Therapeutics, Inc.

Company: Tmunity Therapeutics
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine